Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Sclerosis × Blood Specimen Collection × Clear all

Phase

Status

Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 28 Colorectal Neoplasms 20 Prostatic Neoplasms 12 Neoplastic Cells, Circulating 11 Melanoma 11 Multiple Myeloma 10 Lung Neoplasms 10 Pancreatic Neoplasms 9 Uterine Cervical Neoplasms 7 Ovarian Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Papillomavirus Infections 5 Neoplasm Metastasis 5 Lymphoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 COVID-19 4 Urinary Bladder Neoplasms 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Liver Neoplasms 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3

Interventions

Interferon beta-1b 2 nabiximols 1 Platelet Transfusion 1 OM 89 1 Mn-PyC3A 1 Magnetic Resonance Imaging 1 Interferon beta-1a 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04844489 2023-02-06

COVIVAC-ID

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

COVID-19, Multiple Sclerosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡